<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04130646</url>
  </required_header>
  <id_info>
    <org_study_id>00089851</org_study_id>
    <nct_id>NCT04130646</nct_id>
  </id_info>
  <brief_title>Noninvasive VNS to Facilitate Excitability in Motor Cortex</brief_title>
  <official_title>Combining Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Transcranial Magnetic Stimulation (TMS) to Enhance Cortical Excitability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcranial Magnetic Stimulation (TMS) positively influences motor rehabilitation in stroke&#xD;
      recovery. Transcutaneous auricular vagus nerve stimulation (taVNS) has shown effects on&#xD;
      cortical plasticity. We investigate whether combination of TMS and taVNS is more effective at&#xD;
      motor cortex excitability than either modality alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to determine the effects of taVNS on motor cortex excitability. The&#xD;
      hypothesis is that taVNS alone (sham rTMS + active taVNS) will induce increases in motor&#xD;
      cortex excitability (post-stimulation compared to baseline). The investigators expect these&#xD;
      changes will be of a lesser magnitude than those of TMS alone (active rTMS + sham taVNS) due&#xD;
      to the indirect mechanistic approach of taVNS. Another aim is to determine whether&#xD;
      taVNS-paired TMS is more effective at inducing cortical excitability than TMS alone, as it is&#xD;
      hypothesized that pairing two forms of neuromodulation (active rTMS + active taVNS) will&#xD;
      increase TMS-induced cortical excitability in the motor cortex when compared to single&#xD;
      modality approaches (active rTMS + sham taVNS; sham rTMS + active taVNS). Furthermore, it is&#xD;
      expected that this increase is timing sensitive, and the paired approach will induce larger&#xD;
      TMS-induced cortical excitability compared to unpaired neuromodulation (active taVNS + active&#xD;
      taVNS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change of EMG-recorded Motor-evoked potential from baseline to immediately after intervention</measure>
    <time_frame>Every 5 minutes up to 20 minutes following intervention end</time_frame>
    <description>The study uses Motor Evoked Potentials (MEPs), which are EMG measurements of a targeted movement (in other words, electromyography on the thenar muscles will sense a &quot;twitch&quot; that may occur due to motor cortex stimulation by TMS). The sensitivity of the motor cortex to stimulation is correlated to the degree of thumb twitch. This MEP will be used as a functional measure of changes in motor cortex excitability, as the amount of muscle twitch (MEP) should change if the cortex is more sensitive to TMS stimulation. The baseline measurement will be taken in the 60 seconds preceding the intervention; the intervention will last 20 minutes; post-intervention MEPs will be measured at 1, 5, 10, 15, and 20 minutes following the end of the intervention.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Stroke</condition>
  <condition>Stroke Sequelae</condition>
  <condition>Motor Activity</condition>
  <arm_group>
    <arm_group_label>Active taVNS, Active TMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham taVNS, Active TMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Active taVNS, Sham TMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham taVNS, Sham TMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>transcranial magnetic stimulation delivers magnetic pulses to the brain through the scalp/skull</description>
    <arm_group_label>Active taVNS, Active TMS</arm_group_label>
    <arm_group_label>Active taVNS, Sham TMS</arm_group_label>
    <arm_group_label>Sham taVNS, Active TMS</arm_group_label>
    <arm_group_label>Sham taVNS, Sham TMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous auricular vagus nerve stimulation (taVNS)</intervention_name>
    <description>non-invasive vagus nerve stimulation delivers electricity to the ear</description>
    <arm_group_label>Active taVNS, Active TMS</arm_group_label>
    <arm_group_label>Active taVNS, Sham TMS</arm_group_label>
    <arm_group_label>Sham taVNS, Active TMS</arm_group_label>
    <arm_group_label>Sham taVNS, Sham TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-80&#xD;
&#xD;
          -  endorsing good health&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no TMS-induced motor cortex excitability changes in response to 20Hz motor cortex rTMS&#xD;
&#xD;
          -  active psychiatric or neurological disorders&#xD;
&#xD;
          -  history of CNS disease, concussion, overnight hospitalization, or other neurologic&#xD;
             sequelae, tumors, seizures, frequent or severe headaches&#xD;
&#xD;
          -  metal implanted above the neck&#xD;
&#xD;
          -  currently taking seizure reducing medications&#xD;
&#xD;
          -  currently taking psychotropic medications&#xD;
&#xD;
          -  any psychotropic medication taken within 5 half-lives of procedure time&#xD;
&#xD;
          -  abuse or dependence of drugs (excluding nicotine and caffeine)&#xD;
&#xD;
          -  currently taking medications that lower the seizure threshold&#xD;
&#xD;
          -  taking any of the stimulants, thyroid medication, or steroids&#xD;
&#xD;
          -  implanted devices/ferrous metal of any kind&#xD;
&#xD;
          -  history of seizure or seizure disorder&#xD;
&#xD;
          -  inability to determine motor threshold.&#xD;
&#xD;
          -  Pregnant females and children under the age of 18 will be excluded for safety reasons&#xD;
&#xD;
          -  No vulnerable populations or special classes of subjects will be considered for&#xD;
             participation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bashar W Badran, PhD</last_name>
    <phone>843-792-6076</phone>
    <email>badran@musc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bashar W Badran, PhD</last_name>
      <email>badran@musc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2019</study_first_posted>
  <last_update_submitted>May 19, 2021</last_update_submitted>
  <last_update_submitted_qc>May 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Bashar Badran</investigator_full_name>
    <investigator_title>Dr. Badran, PhD</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>recovery</keyword>
  <keyword>TMS</keyword>
  <keyword>VNS</keyword>
  <keyword>motor</keyword>
  <keyword>motor cortex</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share data except through peer-review.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

